Tag: commercialization

CEL-SCI’s Multikine Cancer Drug May Launch in Saudi Arabia by 2025

May 21, 2025

Saudi Food and Drug Authority typically responds to Breakthrough Medicine Designation applications within approximately 60 days CEL-SCI Corporation announced it has completed its Breakthrough Medicine Designation

Ferrer Partners with Prilenia for Pridopidine Co-Development

April 28, 2025

Ferrer, an international B Corp pharmaceutical company with an increasing focus on rare neurological diseases, and Prilenia Therapeutics B.V.,a clinical-stage biotech company, have announced the signing

Factor 7 Medical Expands Leadership and Service Areas

March 8, 2025

Following a leadership consolidation and the launch of a strategic growth plan last year, F7 Medical’s executive additions strengthen its expertise in five growth areas

Categories

Tag: commercialization

CEL-SCI’s Multikine Cancer Drug May Launch in Saudi Arabia by 2025

Ferrer Partners with Prilenia for Pridopidine Co-Development

Factor 7 Medical Expands Leadership and Service Areas

Share With

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup

FCL Names Mike Davis as New CEO to Drive Growth

Kelly Roberts Joins CoreCare to Lead AI in Reimbursement

HR HealthCare Enhances Customer Experience with New Website

AI Chatbots Are the New Frontline in Mental Health Support

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands